메뉴 건너뛰기




Volumn 14, Issue 1, 2014, Pages

CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro

Author keywords

Breast cancer; CDK2 AP1; Cell cycle; Chemotherapy sensitivity

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2 ASSOCIATE PROTEIN 1; DOCETAXEL; EPIRUBICIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

EID: 84988624569     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-014-0130-8     Document Type: Article
Times cited : (28)

References (18)
  • 1
    • 84988635370 scopus 로고    scopus 로고
    • International Agency for Research on Cancer [http://globocan.iarc.fr/Pages/ fact_sheets_cancer.aspx]
  • 2
    • 61749103821 scopus 로고    scopus 로고
    • Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells
    • Choi EJ, Kim GH: Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem 2009, 20:285-290.
    • (2009) J Nutr Biochem , vol.20 , pp. 285-290
    • Choi, E.J.1    Kim, G.H.2
  • 3
    • 34248195589 scopus 로고    scopus 로고
    • Tumors initiate by constructive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression
    • Corsino P, Davis B, Law M, Chytil A, Forrester E, Nrgaard P, Teoh N, Law B: Tumors initiate by constructive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Cancer Res 2007, 67:3135-3144.
    • (2007) Cancer Res , vol.67 , pp. 3135-3144
    • Corsino, P.1    Davis, B.2    Law, M.3    Chytil, A.4    Forrester, E.5    Nrgaard, P.6    Teoh, N.7    Law, B.8
  • 6
    • 79955490608 scopus 로고    scopus 로고
    • Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E
    • Akli S, Van Pelt CS, Bui T, Meijer L, Keyomarsi K: Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E. Cancer Res 2011, 71:3377-3386.
    • (2011) Cancer Res , vol.71 , pp. 3377-3386
    • Akli, S.1    Van Pelt, C.S.2    Bui, T.3    Meijer, L.4    Keyomarsi, K.5
  • 8
    • 79951807772 scopus 로고    scopus 로고
    • Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-positive breast cancer cells
    • Wesierska-Gadek J, Gritsch D, Zulehner N, Komina O, Maurer M: Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-positive breast cancer cells. J Cell Biochem 2011, 112:761-772.
    • (2011) J Cell Biochem , vol.112 , pp. 761-772
    • Wesierska-Gadek, J.1    Gritsch, D.2    Zulehner, N.3    Komina, O.4    Maurer, M.5
  • 9
    • 75549090821 scopus 로고    scopus 로고
    • Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
    • Johnson N, Bentley J, Wang LZ, Newell DR, Robson CN, Shapiro GI, Curtin NJ: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. Br J Cancer 2010, 102:342-350.
    • (2010) Br J Cancer , vol.102 , pp. 342-350
    • Johnson, N.1    Bentley, J.2    Wang, L.Z.3    Newell, D.R.4    Robson, C.N.5    Shapiro, G.I.6    Curtin, N.J.7
  • 12
    • 1642475176 scopus 로고    scopus 로고
    • Role of p12 (CDK2-AP1) in transforming growth factor beta 1 mediated growth suppression
    • Hu MG, Hu GF, Kim Y, Tsuji T, McBride J, Hinds P, Wong DT: Role of p12 (CDK2-AP1) in transforming growth factor beta 1 mediated growth suppression. Cancer Res 2004, 64:490-499.
    • (2004) Cancer Res , vol.64 , pp. 490-499
    • Hu, M.G.1    Hu, G.F.2    Kim, Y.3    Tsuji, T.4    McBride, J.5    Hinds, P.6    Wong, D.T.7
  • 13
    • 33845595885 scopus 로고    scopus 로고
    • Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad sigaling pathway
    • Peng H, Shintani S, Kim Y, Wong DT: Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad sigaling pathway. Neoplasia 2006, 8:1028-1036.
    • (2006) Neoplasia , vol.8 , pp. 1028-1036
    • Peng, H.1    Shintani, S.2    Kim, Y.3    Wong, D.T.4
  • 14
    • 13244266955 scopus 로고    scopus 로고
    • P12(CDK2-AP1) mediates DNA damage responses induced by cisplatin
    • Kim Y, McBride J, Zhang R, Zhou X, Wong DT: P12(CDK2-AP1) mediates DNA damage responses induced by cisplatin. Oncogene 2005, 24:407-418.
    • (2005) Oncogene , vol.24 , pp. 407-418
    • Kim, Y.1    McBride, J.2    Zhang, R.3    Zhou, X.4    Wong, D.T.5
  • 15
    • 61849170565 scopus 로고    scopus 로고
    • Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues
    • Choi MG, Sohn TS, Park SB, Paik YH, Noh JH, Kim KM, Park CK, Kim S: Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues. Eur Surg Res 2009, 42:223-229.
    • (2009) Eur Surg Res , vol.42 , pp. 223-229
    • Choi, M.G.1    Sohn, T.S.2    Park, S.B.3    Paik, Y.H.4    Noh, J.H.5    Kim, K.M.6    Park, C.K.7    Kim, S.8
  • 17
    • 69449084550 scopus 로고    scopus 로고
    • Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function
    • Zolochevska O, Figueiredo ML: Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function. Prostate 2009, 69:1586-1597.
    • (2009) Prostate , vol.69 , pp. 1586-1597
    • Zolochevska, O.1    Figueiredo, M.L.2
  • 18
    • 84871307708 scopus 로고    scopus 로고
    • p12CDK2-AP1 inhibits breast cancer cell proliferation and in vivo tumor growth
    • Zhou W, Guan X, Wang L, Liao Y, Huang J: p12CDK2-AP1 inhibits breast cancer cell proliferation and in vivo tumor growth. J Cancer Res Clin Oncol 2012, 138:2085-2093.
    • (2012) J Cancer Res Clin Oncol , vol.138 , pp. 2085-2093
    • Zhou, W.1    Guan, X.2    Wang, L.3    Liao, Y.4    Huang, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.